JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (5): 459-462.doi: 10.3969/j.issn.1005-6483.2022.05.016

Previous Articles     Next Articles

The value of mGPS score combined with FPR ratio in the prognostic evaluation of thoracoscopic lobectomy for lung cancer

  

  1. Department of Cardiothoracic Surgery,Huanggang Central Hospital,Hubei,Huanggang 438000, China
  • Received:2021-08-16 Accepted:2021-08-16 Online:2022-05-20 Published:2022-06-20

Abstract: [Abstract] Objective To investigate the value of modified Glasgow prognostic score(mGPS)  combined with Fibrinogen to pre-albumin ratio(FPR) in the prognostic evaluation of thoracoscopic lobectomy for lung cancer.Methods The clinical and follow-up data of 63 patients with lung cancer who underwent thoracoscopic lobectomy in Huanggang Central Hospital from October 2016 to December 2019 were retrospectively analyzed.FPR of patients before surgery was detected and calculated,and the mGPS was recorded.The receiver operating characteristic curve(ROC) was used to determine the optimal cut-off value of FPR,and χ2 test was used to analyze the relationship between mGPS,FPR and the clinicopathological characteristics of lung cancer,and single factor and multivariate Cox proportional hazard regression models were used to analyze the influence factors related to the prognosis of patients with lung cancer underwent thoracoscopic lobectomy.Results According to the mGPS,0 points were included in the normal group(38 cases),and 1~2 points were included in the abnormal group(25 cases).The best cutoff value of FPR by ROC curve was 0.096,and the patients were divided into the high FPR group(FPR>0.096,n=19) and low FPR group(FPR≤0.096,n=44).The proportion of TNM III stage in lung cancer patients with abnormal mGPS and high FPR was higher(P<0.05).The 3 year disease-free survival rate of the normal mGPS group and the low FPR group was higher than that of the abnormal mGPS group and the high FPR group(78.95% vs 48.00%,75.00% vs 47.37%)(P<0.05).The 3 year disease-free survival rate of 18 patients with abnormal mGPS combined with FPR(abnormal mGPS and high FPR) was 38.89%,which was significantly lower than that of the two non-uniform abnormal lung cancer patients(77.78%,P<0.05).TNM stage Ⅲ,abnormal mGPS,high FPR,and abnormal mGPS combined with FPR(abnormal mGPS and high FPR) were all independent risk factors of the prognosis of lung cancer patients after thoracoscopic lobectomy(P<0.05).Conclusion he survival rate of lung cancer patients undergoing thoracoscopic lobectomy with abnormal preoperative mGPS or high FPR is significantly reduced,and the survival rate of patients with both abnormalities is lower.The combination of mGPS and FPR is expected to be an effective indicator for evaluating the prognosis of lung cancer patients.

Key words: modified Glasgow prognostic score, fibrinogen to pre-albumin ratio, thoracoscopic lobectomy, lung cancer

[1] YE Bin, XIANG Qiu, JIN Wenjie. Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 453-458.
[2] CHEN Yu, YAO Long, WANG Yunhai , et al.. Comparison of the perioperative related indicators of thoracoscopic segmentectomy and wedge resection in the treatment of early stage lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 51-53.
[3] . Efficacy and safety of Flexthreedimensional thoracoscopic lobectomy and lymph node dissection in the treatment of primary lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 717-720.
[4] ZHENG Yanhong, LIANG Zhu, MA Bingtai, et al.. Relationship between lymph node metastasis and clinical pathology in patients with left lung cancer resection combined with regional lymph node dissection [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(5): 463-465.
[5] WAN Zhihua, WU Ruifeng, LIU Weiming, et al.. Efficacy of 3D thoracoscopic lobectomy in the treatment of primary lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(3): 269-272.
[6] . Effect of total thoracoscopic surgery on tumor markers NSE,PCT,immune markers CD3+,CD4+ and CD8+ in lung cancer patients and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(2): 140-142.
[7] WANG Xianguo, LIU Jun.. A retrospective study of segmentectomy and wedge resection in the treatment of peripheral lung cancer with a diameter of ≤2cm [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1044-1046.
[8] SUN Linao, LI Changsheng, ZHOU Xuefeng.. Expression and clinical significance of Glycine N-methyltransferase in lung cancer and adjacent tissues [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 945-948.
[9] BAIDURULA·Ainitu, KAISAER·Wufuer, FU Yi, et al.. Effect of lobectomy and sublobar lobectomy on pulmonary function and recurrence in elderly patients with early NSCLC [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 949-952.
[10] ZHOU Chao, LI Wentao, WANG Rui, et al. Clinical analysis of 13 cases of synchronous multiple primary lung cancer treated by the combination of thoracoscopy and bronchoscopy [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(1): 38-41.
[11] LI Zengliang, PAN Yanqing, MA Guodong.. Predictive value of CTR in patients with multiple ground-glass opacity (GGO) nodules [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(9): 841-844.
[12] WANG Xunhao, SHEN Lei, DAI Xiyong.. Clinical analysis of 52 patients with lung cancer complicated with pulmonary tuberculosis [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(7): 647-649.
[13] DENG Yu, HAO Bo, GENG Qing.. Current status and prospect of treatment for small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(7): 696-699.
[14] . The correlation study of preoperative platelet to lymphocyte ratio,neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio on the prognosis of patients with nonsmall cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(11): 1020-1024.
[15] TENG Jiping, YANG Zhiyin, HU Xiaohua.. The efficacy of gefitinib versus pemetrexed combined with nedaplatin in patients with stage ⅢA-N2 EGFR mutation-positive lung adenocarcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(10): 938-942.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 816 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 819 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 821 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 824 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 828 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 831 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 835 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 839 .